The Maryland Proton Treatment Center has raised more than $277 million in new funding, slashing its debt by about 35 percent as the facility struggles to gain financial footing since opening in early 2016.
The center raised the capital through the sale of tax-free municipal bonds as part of a deal backed by the Public Finance Authority of Wisconsin.
Located at the University of Maryland BioPark, the 110,000-square-foot cancer treatment facility has faced challenges in drawing enough patients to…
